$1.35
0.021.5%
Last update: Nov 12, 7:38 AM
NervGen Pharma Corp (NGEN) Stock Price, Quote, News & History
NGENNASDAQ
NGEN stock climbs as NervGen Pharma NVG-291 hits a 100% responder rate in spinal cord injury gait analysis. Phase 3 set for mid-2026.
You can purchase shares of NervGen Pharma (NASDAQ:NGEN) through any online brokerage.
Other companies in NervGen Pharma’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
NervGen Pharma has a consensus price target of $12.50.
The stock price for NervGen Pharma (NASDAQ: NGEN) is $1.43 last updated November 12, 2026 at 7:38 AM EST.
There are no upcoming dividends for NervGen Pharma.
NervGen Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for NervGen Pharma.
NervGen Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery,...
